<DOC>
	<DOCNO>NCT00541450</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety sitagliptin MK0431A comparison commonly use medication patient type 2 diabetes .</brief_summary>
	<brief_title>A Study Evaluate Efficacy Safety Sitagliptin MK0431A Comparison Commonly Used Medication Patients With Type 2 Diabetes ( 0431-068 ) ( COMPLETED )</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Pioglitazone</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Sitagliptin Phosphate</mesh_term>
	<criteria>Patients age 18 78 type 2 diabetes mellitus Patient antihyperglycemic agent ( Insulin oral ) last 3 month Patient history type 1 diabetes mellitus history ketoacidosis Patient previously treat sitagliptin previously study use DPP4 inhibitor</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>78 Years</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>